Wie man die anderen verstehen soll und wie man über sie schreiben kann. Der Paris-Bericht Rifāʿa Rāfiʿ aṭ-Ṭahṭāwīs (1801-1873) als vielseitige Vermittlung von 'Kultur'

Im vorliegenden Essay wird eine Lesart des viel diskutierten Paris-Berichts von Rifāʿa aṭ-Ṭahṭāwī vorgestellt. Kontrastierend zu der Annahme, Ṭahṭāwī habe eine Reise aus einer Kultur in eine andere unternommen, soll hier dargelegt werden, wie sich aus dem Text des Ägypters ein eigenes Kulturverständnis erschließen lässt. Besonders Ṭahṭāwīs Bemühungen um die Übersetzung des französischen Begriffs 'civilisation' deuten auf ein plurales Verständnis von 'Kultur'. Denn im Text lassen sich diejenigen Dimensionen des Begriffs 'Kultur' finden, die auch aus der europäischen Geistesgeschichte rekonstruiert werden können: Kultur als bestimmter Lebensstil, als Prozessbegriff zur Beschreibung gesellschaftlicher Entwicklung und als kreative oder künstlerische Aktivität.

Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is the most frequent form of primary liver cancer and chronic infection with hepatitis C virus is one of the main risk factors for HCC. This study analyses the characteristics of the patients with chronic hepatitis C participating in the Swiss Hepatitis C Cohort Study who developed HCC.

Appropriateness and long-term discontinuation rate of biological therapies in ulcerative colitis

BACKGROUND Anti-TNFα agents are commonly used for ulcerative colitis (UC) therapy in the event of non-response to conventional strategies or as colon-salvaging therapy. The objectives were to assess the appropriateness of biological therapies for UC patients and to study treatment discontinuation over time, according to appropriateness of treatment, as a measure of outcome. METHODS We selected adult ulcerative colitis patients from the Swiss IBD cohort who had been treated with anti-TNFα agents. Appropriateness of the first-line anti-TNFα treatment was assessed using detailed criteria developed during the European Panel on the Appropriateness of Therapy for UC. Treatment discontinuation as an outcome was assessed for categories of appropriateness. RESULTS Appropriateness of the first-line biological treatment was determined in 186 UC patients. For 64% of them, this treatment was considered appropriate. During follow-up, 37% of all patients discontinued biological treatment, 17% specifically because of failure. Time-to-failure of treatment was significantly different among patients on an appropriate biological treatment compared to those for whom the treatment was considered not appropriate (p=0.0007). Discontinuation rate after 2years was 26% compared to 54% between those two groups. Patients on inappropriate biological treatment were more likely to have severe disease, concomitant steroids and/or immunomodulators. They were also consistently more likely to suffer a failure of efficacy and to stop therapy during follow-up. CONCLUSION Appropriateness of first-line anti-TNFα therapy results in a greater likelihood of continuing with the therapy. In situations where biological treatment is uncertain or inappropriate, physicians should consider other options instead of prescribing anti-TNFα agents.